Ausgabe 4/2002
Inhalt (15 Artikel)
Does Leucovorin Alter the Intratumoral Pharmacokinetics of 5-Fluorouracil (5-FU)? A Southwest Oncology Group Study
Cary A. Presant, Joth Jacobson, Walter Wolf, Victor Waluch, Ilene C. Weitz, John S. Macdonald
Phase I Study of Eniluracil, Oral 5-Fluororacil and Gemcitabine in Patients with Advanced Malignancy
Sherry Morgan-Meadows, James P. Thomas, Daniel Mulkerin, Jordan D. Berlin, Howard Bailey, Kim Binger, Jennifer Volkman, Dona Alberti, Chris Feierabend, Rebecca Marrocha, Rhoda Z. Arzoomanian, George Wilding
Phase I Escalation of Gemcitabine Combined with Protracted Oral Etoposide in Gynecologic Malignancies – A Gynecologic Oncology Group Study
Agustin A. Garcia, Michael A. Bookman, Lorna Rodriguez-Rodriguez, David G. Mutch, Katherine Y. Look
A Phase II Study of Thalidomide in Advanced Metastatic Renal Cell Carcinoma
David R. Minor, Dana Monroe, Lisa A. Damico, Gloria Meng, Uma Suryadevara, Laurence Elias
Licensure of Gemtuzumab Ozogamicin for the Treatment of Selected Patients 60 Years of Age or Older with Acute Myeloid Leukemia in First Relapse
Mark S. Berger, Lance H. Leopold, James A. Dowell, Joan M. Korth-Bradley, Matthew L. Sherman
A Randomized Phase II Study of Two Schedules of Bryostatin-1 (NSC339555) in Patients with Advanced Malignant Melanoma – A National Cancer Institute of Canada Clinical Trials Group Study
R.G. Tozer, S. Burdette-Radoux, K. Berlanger, M.L. Davis, R.C. Lohmann, J.R. Rusthoven, N. Wainman, B. Zee, L. Seymour
Irofulven, a Novel Inhibitor of DNA Synthesis, in Metastatic Renal Cell Cancer
Robert J. Amato, Cherie Perez, Lance Pagliaro
Biochemical Modulation of 5-Fluorouacil Through Dihydropyrimidine Dehydrogenase Inhibition: a Southwest Oncology Group Phase II Trial of Eniluracil and 5-Fluorouracil in Advanced Resistant Colorectal Cancer
Cynthia G. Leichman, Kari Chansky, John S. Macdonald, Michael A. Doukas, G. Thomas Budd, Jeffrey K. Giguere, James L. Abbruzzese
Piritrexim in Advanced, Refractory Carcinoma of the Urothelium (E3896): A Phase II Trial of the Eastern Cooperative Oncology Group
Bruce J. Roth, Judith Manola, Robert Dreicer, David Graham, George Wilding
Phase II Study of Marimastat (BB-2516) in Malignant Melanoma – A Clinical and Tumor Biopsy Study of the National Cancer Institute of Canada Clinical Trials Group
Ian Quirt, Audley Bodurtha, Reinhard Lohmann, James Rusthoven, Karl Belanger, Vincent Young, Nancy Wainman, William Steward, Elizabeth Eisenhauer
Neoadjuvant Chemotherapy with Gemcitabine and Cisplatin in Stage IIIA/B Non-Small Cell Lung Cancer
Maximiliano Van Kooten, Moisés Rosenberg, Mauro Orlando, José Morero, Manuel Vilanova, Oscar Rojas, Héctor Vicente, Claudia Bagnes, Carlos Silva, Reinaldo D. Chacón